Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001191248-10-000005
Filing Date
2010-12-03
Accepted
2010-12-03 17:10:25
Documents
1
Period of Report
2010-12-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3509
  Complete submission text file 0001191248-10-000005.txt   5239
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02149
Business Address
BEST LAWRENCE C (Reporting) CIK: 0001191248 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 101232257